(ASML) ASML Holding - Ratings and Ratios
Exchange: AS •
Country: Netherlands •
Currency: EUR •
Type: Common Stock •
ISIN: NL0010273215
Lithography, Metrology, Inspection, Software, Services
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 0.95% |
| Yield on Cost 5y | 1.49% |
| Yield CAGR 5y | 18.29% |
| Payout Consistency | 85.1% |
| Payout Ratio | 27.1% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 37.5% |
| Value at Risk 5%th | 55.1% |
| Relative Tail Risk | -10.66% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.58 |
| Alpha | 74.82 |
| CAGR/Max DD | 0.55 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.549 |
| Beta | 0.466 |
| Beta Downside | 0.565 |
| Drawdowns 3y | |
|---|---|
| Max DD | 44.77% |
| Mean DD | 16.75% |
| Median DD | 12.07% |
Description: ASML ASML Holding December 11, 2025
ASML Holding N.V. designs, manufactures, and services lithography equipment that patterns silicon wafers for semiconductor fabs. Its portfolio spans extreme-ultraviolet (EUV) systems, deep-ultraviolet (DUV) immersion and dry tools, metrology/inspection solutions (e.g., YieldStar and HMI electron-beam), and computational lithography software, plus aftermarket upgrades and customer support.
In FY 2023 the company reported €21.2 billion in revenue, with a gross margin of roughly 48 % and an R&D intensity near 24 % of sales, reflecting the capital-intensive nature of EUV development. The order backlog-about €30 billion at year-end-provides visibility into demand for next-generation nodes (7 nm and below).
ASML’s growth is tightly linked to macro drivers such as the global shift toward AI-enabled data centers, 5G infrastructure, and automotive electrification, all of which increase demand for smaller, more power-efficient chips. A critical sector constraint is the limited number of EUV suppliers; ASML’s near-monopoly in high-NA EUV positions it as a bottleneck-free source of capacity, but also subjects it to geopolitical risk in its key markets (China, Taiwan, South Korea).
For a deeper dive into valuation metrics and scenario analysis, you may find the ASML page on ValueRay useful.
Piotroski VR‑10 (Strict, 0-10) 9.0
| Net Income: 9.46b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.20 > 0.02 and ΔFCF/TA 13.03 > 1.0 |
| NWC/Revenue: 18.38% < 20% (prev 33.69%; Δ -15.30% < -1%) |
| CFO/TA 0.24 > 3% & CFO 10.79b > Net Income 9.46b |
| Net Debt (-8.05b) to EBITDA (9.57b): -0.84 < 3 |
| Current Ratio: 1.31 > 1.5 & < 3 |
| Outstanding Shares: last quarter (388.1m) vs 12m ago -1.39% < -2% |
| Gross Margin: 52.71% > 18% (prev 0.51%; Δ 5220 % > 0.5%) |
| Asset Turnover: 74.17% > 50% (prev 62.82%; Δ 11.35% > 0%) |
| Interest Coverage Ratio: 57.50 > 6 (EBITDA TTM 9.57b / Interest Expense TTM 153.7m) |
Altman Z'' 3.87
| A: 0.13 (Total Current Assets 25.15b - Total Current Liabilities 19.22b) / Total Assets 45.10b |
| B: 0.32 (Retained Earnings 14.41b / Total Assets 45.10b) |
| C: 0.20 (EBIT TTM 8.84b / Avg Total Assets 43.43b) |
| D: 0.57 (Book Value of Equity 14.90b / Total Liabilities 26.10b) |
| Altman-Z'' Score: 3.87 = AA |
Beneish M -3.16
| DSRI: 0.65 (Receivables 5.36b/6.68b, Revenue 32.21b/26.24b) |
| GMI: 0.97 (GM 52.71% / 51.15%) |
| AQI: 1.07 (AQ_t 0.26 / AQ_t-1 0.25) |
| SGI: 1.23 (Revenue 32.21b / 26.24b) |
| TATA: -0.03 (NI 9.46b - CFO 10.79b) / TA 45.10b) |
| Beneish M-Score: -3.16 = AA |
ValueRay F-Score (Strict, 0-100) 90.36
| 1. Piotroski: 9.0pt |
| 2. FCF Yield: 1.98% |
| 3. FCF Margin: 27.76% |
| 4. Debt/Equity: 0.25 |
| 5. Debt/Ebitda: -0.84 |
| 6. ROIC - WACC: 79.84% |
| 7. RoE: 52.15% |
| 8. Revenue Trend: 74.84% |
| 9. EPS Trend: 56.97% |
What is the price of ASML shares?
As of January 24, 2026, the stock is trading at EUR 1178.20 with a total of 640,326 shares traded.
Over the past week, the price has changed by +0.94%, over one month by +30.45%, over three months by +32.96% and over the past year by +66.32%.
Over the past week, the price has changed by +0.94%, over one month by +30.45%, over three months by +32.96% and over the past year by +66.32%.
Is ASML a buy, sell or hold?
ASML Holding has no consensus analysts rating.
What are the forecasts/targets for the ASML price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 1139.7 | -3.3% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 1445.6 | 22.7% |
ASML Fundamental Data Overview January 20, 2026
Market Cap USD = 528.84b (453.05b EUR * 1.1673 EUR.USD)
P/E Trailing = 48.0725
P/E Forward = 44.4444
P/S = 14.0645
P/B = 23.8527
P/EG = 2.4822
Revenue TTM = 32.21b EUR
EBIT TTM = 8.84b EUR
EBITDA TTM = 9.57b EUR
Long Term Debt = 2.70b EUR (from longTermDebt, last quarter)
Short Term Debt = 1.01b EUR (from shortTermDebt, last fiscal year)
Debt = 4.69b EUR (from shortLongTermDebtTotal, last fiscal year)
Net Debt = -8.05b EUR (from netDebt column, last fiscal year)
Enterprise Value = 452.61b EUR (453.05b + Debt 4.69b - CCE 5.13b)
Interest Coverage Ratio = 57.50 (Ebit TTM 8.84b / Interest Expense TTM 153.7m)
EV/FCF = 50.61x (Enterprise Value 452.61b / FCF TTM 8.94b)
FCF Yield = 1.98% (FCF TTM 8.94b / Enterprise Value 452.61b)
FCF Margin = 27.76% (FCF TTM 8.94b / Revenue TTM 32.21b)
Net Margin = 29.38% (Net Income TTM 9.46b / Revenue TTM 32.21b)
Gross Margin = 52.71% ((Revenue TTM 32.21b - Cost of Revenue TTM 15.23b) / Revenue TTM)
Gross Margin QoQ = 51.63% (prev 53.69%)
Tobins Q-Ratio = 10.04 (Enterprise Value 452.61b / Total Assets 45.10b)
Interest Expense / Debt = 3.28% (Interest Expense 153.7m / Debt 4.69b)
Taxrate = 17.77% (442.2m / 2.49b)
NOPAT = 7.27b (EBIT 8.84b * (1 - 17.77%))
Current Ratio = 1.31 (Total Current Assets 25.15b / Total Current Liabilities 19.22b)
Debt / Equity = 0.25 (Debt 4.69b / totalStockholderEquity, last quarter 18.99b)
Debt / EBITDA = -0.84 (Net Debt -8.05b / EBITDA 9.57b)
Debt / FCF = -0.90 (Net Debt -8.05b / FCF TTM 8.94b)
Total Stockholder Equity = 18.15b (last 4 quarters mean from totalStockholderEquity)
RoA = 21.79% (Net Income 9.46b / Total Assets 45.10b)
RoE = 52.15% (Net Income TTM 9.46b / Total Stockholder Equity 18.15b)
RoCE = 42.38% (EBIT 8.84b / Capital Employed (Equity 18.15b + L.T.Debt 2.70b))
RoIC = 87.42% (NOPAT 7.27b / Invested Capital 8.31b)
WACC = 7.58% (E(453.05b)/V(457.73b) * Re(7.63%) + D(4.69b)/V(457.73b) * Rd(3.28%) * (1-Tc(0.18)))
Discount Rate = 7.63% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -0.69%
[DCF Debug] Terminal Value 74.65% ; FCFF base≈6.50b ; Y1≈4.80b ; Y5≈2.78b
Fair Price DCF = 167.0 (EV 56.77b - Net Debt -8.05b = Equity 64.82b / Shares 388.1m; r=7.58% [WACC]; 5y FCF grow -30.84% → 2.90% )
[DCF Warning] FCF declining rapidly (-30.84%), DCF may be unreliable
EPS Correlation: 56.97 | EPS CAGR: 9.32% | SUE: 0.71 | # QB: 0
Revenue Correlation: 74.84 | Revenue CAGR: 11.57% | SUE: -1.29 | # QB: 0
EPS next Quarter (2026-03-31): EPS=5.86 | Chg30d=+0.257 | Revisions Net=+0 | Analysts=13
EPS next Year (2026-12-31): EPS=26.92 | Chg30d=+0.996 | Revisions Net=+9 | Growth EPS=+8.3% | Growth Revenue=+7.7%
P/E Trailing = 48.0725
P/E Forward = 44.4444
P/S = 14.0645
P/B = 23.8527
P/EG = 2.4822
Revenue TTM = 32.21b EUR
EBIT TTM = 8.84b EUR
EBITDA TTM = 9.57b EUR
Long Term Debt = 2.70b EUR (from longTermDebt, last quarter)
Short Term Debt = 1.01b EUR (from shortTermDebt, last fiscal year)
Debt = 4.69b EUR (from shortLongTermDebtTotal, last fiscal year)
Net Debt = -8.05b EUR (from netDebt column, last fiscal year)
Enterprise Value = 452.61b EUR (453.05b + Debt 4.69b - CCE 5.13b)
Interest Coverage Ratio = 57.50 (Ebit TTM 8.84b / Interest Expense TTM 153.7m)
EV/FCF = 50.61x (Enterprise Value 452.61b / FCF TTM 8.94b)
FCF Yield = 1.98% (FCF TTM 8.94b / Enterprise Value 452.61b)
FCF Margin = 27.76% (FCF TTM 8.94b / Revenue TTM 32.21b)
Net Margin = 29.38% (Net Income TTM 9.46b / Revenue TTM 32.21b)
Gross Margin = 52.71% ((Revenue TTM 32.21b - Cost of Revenue TTM 15.23b) / Revenue TTM)
Gross Margin QoQ = 51.63% (prev 53.69%)
Tobins Q-Ratio = 10.04 (Enterprise Value 452.61b / Total Assets 45.10b)
Interest Expense / Debt = 3.28% (Interest Expense 153.7m / Debt 4.69b)
Taxrate = 17.77% (442.2m / 2.49b)
NOPAT = 7.27b (EBIT 8.84b * (1 - 17.77%))
Current Ratio = 1.31 (Total Current Assets 25.15b / Total Current Liabilities 19.22b)
Debt / Equity = 0.25 (Debt 4.69b / totalStockholderEquity, last quarter 18.99b)
Debt / EBITDA = -0.84 (Net Debt -8.05b / EBITDA 9.57b)
Debt / FCF = -0.90 (Net Debt -8.05b / FCF TTM 8.94b)
Total Stockholder Equity = 18.15b (last 4 quarters mean from totalStockholderEquity)
RoA = 21.79% (Net Income 9.46b / Total Assets 45.10b)
RoE = 52.15% (Net Income TTM 9.46b / Total Stockholder Equity 18.15b)
RoCE = 42.38% (EBIT 8.84b / Capital Employed (Equity 18.15b + L.T.Debt 2.70b))
RoIC = 87.42% (NOPAT 7.27b / Invested Capital 8.31b)
WACC = 7.58% (E(453.05b)/V(457.73b) * Re(7.63%) + D(4.69b)/V(457.73b) * Rd(3.28%) * (1-Tc(0.18)))
Discount Rate = 7.63% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -0.69%
[DCF Debug] Terminal Value 74.65% ; FCFF base≈6.50b ; Y1≈4.80b ; Y5≈2.78b
Fair Price DCF = 167.0 (EV 56.77b - Net Debt -8.05b = Equity 64.82b / Shares 388.1m; r=7.58% [WACC]; 5y FCF grow -30.84% → 2.90% )
[DCF Warning] FCF declining rapidly (-30.84%), DCF may be unreliable
EPS Correlation: 56.97 | EPS CAGR: 9.32% | SUE: 0.71 | # QB: 0
Revenue Correlation: 74.84 | Revenue CAGR: 11.57% | SUE: -1.29 | # QB: 0
EPS next Quarter (2026-03-31): EPS=5.86 | Chg30d=+0.257 | Revisions Net=+0 | Analysts=13
EPS next Year (2026-12-31): EPS=26.92 | Chg30d=+0.996 | Revisions Net=+9 | Growth EPS=+8.3% | Growth Revenue=+7.7%